Christopher Stevens

Christopher Stevens

Chief Operating OfficeratRocket Pharmaceuticals· In the 2025 proxy

Pay in FY2025Rocket Pharmaceuticals stock -72.1% the same year

Christopher Stevens was paid $3.6M in FY2025 (Dec). Rocket Pharmaceuticals stock fell 72.1% that year.

Pay$100 in the stock at the end of FY24 → $28
Pay is from the Summary Compensation Table of each Rocket Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Rocket PharmaceuticalsPublic company · 1 yr
    • Chief Operating Officer2025 – Present · 1 yrStock in role -78%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?